Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator

被引：19

作者：

Angeja, BG

Rundle, AC

Gurwitz, JH

Gore, JM

Barron, HV

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA

[2] Genentech Inc, S San Francisco, CA 94080 USA

[3] Meyers Primary Care Inst, Fallon Healthcare Syst, Worcester, MA USA

[4] Univ Massachusetts, Sch Med, Worcester, MA USA

[5] Univ Massachusetts, Dept Med, Worcester, MA USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 87卷 / 05期

关键词：

D O I：

10.1016/S0002-9149(00)01441-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：627 / 630

页数：4

共 19 条

[1] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
APPLEBY, P
BAIGENT, C
COLLINS, R
FLATHER, M
PARISH, S
PETO, R
BELL, P
HALLS, H
MEAD, G
DIAZ, R
PAOLASSO, E
PAVIOTTI, C
ROMERO, G
CAMPBELL, T
OROURKE, MF
THOMPSON, P
LESAFFRE, E
VANDEWERF, F
VERSTRAETE, M
ARMSTRONG, PW
CAIRNS, JA
MORAN, C
TURPIE, AG
YUSUF, S
GRANDE, P
HEIKKILA, J
KALA, R
BASSAND, JP
BOISSEL, JP
BROCHIER, M
LEIZOROVICZ, A
BRUGGEMANN, T
KARSCH, KR
KASPER, W
LAMMERTS, D
NEUHAUS, KL
MEYER, J
SCHRODER, R
VONESSEN, R
SARAN, RK
ARDISSINO, D
BONADUCE, D
BRUNELLI, C
CERNIGLIARO, C
FORESTI, A
FRANZOSI, MG
GUIDUCCI, D
MAGGIONI, A
MAGNANI, B
MATTIOLI, G
[J]. LANCET, 1994, 343 (8893) : 311 - 322
[2] Barron Hal V., 1999, Circulation, V100
[3] Use of reperfusion therapy for acute myocardial infarction in the United States - Data from the National Registry of Myocardial Infarction 2
Barron, HV
Bowlby, LJ
Breen, T
Rogers, WJ
Canto, JG
Zhang, YA
Tiefenbrunn, AJ
Weaver, WD
[J]. CIRCULATION, 1998, 97 (12) : 1150 - 1156
[4] Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction - Importance of microvascular reperfusion injury on clinical outcome
Claeys, MJ
Bosmans, J
Veenstra, L
Jorens, P
De Raedt, H
Vrints, CJ
[J]. CIRCULATION, 1999, 99 (15) : 1972 - 1977
[5] A comparison of the national registry of myocardial infarction 2 with the Cooperative Cardiovascular Project
Every, NR
Frederick, PD
Robinson, M
Sugarman, J
Bowlby, L
Barron, HV
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) : 1886 - 1894
[6] Coronary thrombolysis for the elderly - Is clinical practice really lagging behind evidence of benefit?
Gurwitz, JH
Goldberg, RJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (21): : 1723 - 1724
[7] Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction
Gurwitz, JH
Gore, JM
Goldberg, RJ
Barron, HV
Breen, T
Rundle, AC
Sloan, MA
French, W
Rogers, WJ
[J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (08) : 597 - +
[8] HAMPTON J, 1993, LANCET, V342, P759
[9] Thrombolytic therapy for eligible elderly patients with acute myocardial infarction
Krumholz, HM
Murillo, JE
Chen, J
Vaccarino, V
Radford, MJ
Ellerbeck, EF
Wang, Y
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (21): : 1683 - 1688
[10] PREDICTORS OF 30-DAY MORTALITY IN THE ERA OF REPERFUSION FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM AN INTERNATIONAL TRIAL OF 41 021 PATIENTS
LEE, KL
WOODLIEF, LH
TOPOL, EJ
WEAVER, WD
BETRIU, A
COL, J
SIMOONS, M
AYLWARD, P
VANDEWERF, F
CALIFF, RM
[J]. CIRCULATION, 1995, 91 (06) : 1659 - 1668

← 1 2 →